Navigating Autism Spectrum Disorder Clinical Trials: COS Team Explores Meaningful Changes with Innovative Methodology
The arena of clinical outcomes research continually beckons for innovative methodologies to decipher and evaluate the intricate details of clinical trials. A striking representation of such pioneering work was displayed at the INSAR 2020 virtual event, a significant gathering of experts dedicated to understanding autism spectrum disorders. We are elated to highlight that our esteemed team from Clinical Outcomes Solutions (COS) was at the forefront of this global congregation, contributing impactful insights.
Presentation Insights
The poster presented by our team, titled “Understanding Meaningful Changes in Autism Spectrum Disorder Clinical Trial Outcomes Using an Exit Interview Methodology”, brings to the fore a fresh perspective. Authored by Dr. Tom Willgoss, Ms. Claire Burbridge, and Dr. Janice Smith, the study delves into using exit interviews to understand the subtle yet meaningful shifts in clinical trial outcomes related to Autism Spectrum Disorder (ASD).
Autism Spectrum Disorder, with its vast heterogeneity in presentation and progression, poses unique challenges when evaluating the efficacy and outcomes of clinical trials. Standard measurement tools might not always capture the nuances of improvements or changes experienced by individuals with ASD. Hence, the approach taken by our team using exit interview methodology serves as a potential game-changer. This method provides a qualitative dimension, offering deeper insights into patient experiences, which often remain unspoken in quantitative assessments.
For those interested in a detailed exploration of the study and its findings, the poster is readily accessible online. Dive deep into the content and understand the methodology, results, and implications through the following link: INSAR 2020 Poster by Willgoss et al.
A Testament to Dedication and Expertise
Presenting at INSAR, a premier platform dedicated to Autism Spectrum Disorder research, underscores our commitment to clinical outcomes research's cutting-edge domains. Accepting our team’s work for this event signifies the quality, relevance, and depth of research COS continues to champion.
Forward Momentum
Clinical Outcomes Solutions remains unwavering in its mission to illuminate the intricacies of clinical trials, making them more comprehensible and relevant to all stakeholders, from clinicians and patients to policymakers. The innovative work showcased by our team at INSAR 2020 is a step in this ongoing journey of excellence.
We sincerely congratulate Dr. Tom Willgoss, Ms. Claire Burbridge, and Dr. Janice Smith for their commendable work and representation at such a distinguished platform.
Stay connected for more insights and developments from the world of Clinical Outcomes Research.